c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Exagen reiterates $72M-$75M 2026 revenue outlook as myositis launch targets early 2027
Seeking Alpha | Nov 10, 2026 1:32 PM EST
Read original article